Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Prepaid Assets: 2015-2024

Historic Prepaid Assets for Seres Therapeutics (MCRB) over the last 10 years, with Dec 2024 value amounting to $5.8 million.

  • Seres Therapeutics' Prepaid Assets fell 49.02% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 49.02%. This contributed to the annual value of $5.8 million for FY2024, which is 27.78% down from last year.
  • Latest data reveals that Seres Therapeutics reported Prepaid Assets of $5.8 million as of FY2024, which was down 27.78% from $8.0 million recorded in FY2023.
  • In the past 5 years, Seres Therapeutics' Prepaid Assets registered a high of $13.4 million during FY2022, and its lowest value of $5.8 million during FY2020.
  • In the last 3 years, Seres Therapeutics' Prepaid Assets had a median value of $8.0 million in 2023 and averaged $9.1 million.
  • As far as peak fluctuations go, Seres Therapeutics' Prepaid Assets soared by 123.80% in 2021, and later crashed by 40.04% in 2023.
  • Over the past 5 years, Seres Therapeutics' Prepaid Assets (Yearly) stood at $5.8 million in 2020, then soared by 123.80% to $12.9 million in 2021, then grew by 3.88% to $13.4 million in 2022, then tumbled by 40.04% to $8.0 million in 2023, then declined by 27.78% to $5.8 million in 2024.